USANA Health Sciences, Inc.

NYSE:USNA Stock Report

Market Cap: US$920.3m

USANA Health Sciences Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Jim Brown

Chief executive officer

US$1.8m

Total compensation

CEO salary percentage34.8%
CEO tenure7.3yrs
CEO ownershipn/a
Management average tenure7.1yrs
Board average tenure6yrs

Recent management updates

Recent updates

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Feb 08
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

Jan 06
Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation

Oct 23

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Sep 09
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

Jul 27
Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

USANA Earnings Preview: From China's Challenge To India's Promise

Jul 21

USANA Health Sciences says Brown will transition to CEO in July 2023

Feb 13

Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

Feb 02
Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates

Oct 25

Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Oct 18
Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Jul 22
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Jul 07
Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Jun 14
Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

May 31
Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside

Apr 28

Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future

Mar 05
Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future

USANA: 15x P/E, 14% Net Cash, Stock Repurchases

Feb 17

A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)

Jan 24
A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)

At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?

Jan 11
At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?

Here's Why I Think USANA Health Sciences (NYSE:USNA) Might Deserve Your Attention Today

Nov 15
Here's Why I Think USANA Health Sciences (NYSE:USNA) Might Deserve Your Attention Today

USANA: Q3 Mixed Results, We See 35% Upside, 15% 10-Year EPS CAGR

Oct 28

USANA: +42% EPS Growth, Upside Of 37%, Rapidly Growing In China Markets

Sep 29

Is Now An Opportune Moment To Examine USANA Health Sciences, Inc. (NYSE:USNA)?

Sep 28
Is Now An Opportune Moment To Examine USANA Health Sciences, Inc. (NYSE:USNA)?

CEO Compensation Analysis

How has Jim Brown's remuneration changed compared to USANA Health Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 30 2023n/an/a

US$64m

Sep 30 2023n/an/a

US$60m

Jul 01 2023n/an/a

US$63m

Apr 01 2023n/an/a

US$65m

Dec 31 2022US$2mUS$624k

US$69m

Oct 01 2022n/an/a

US$77m

Jul 02 2022n/an/a

US$89m

Apr 02 2022n/an/a

US$108m

Jan 01 2022US$2mUS$600k

US$117m

Oct 02 2021n/an/a

US$136m

Jul 03 2021n/an/a

US$139m

Apr 03 2021n/an/a

US$129m

Jan 02 2021US$2mUS$599k

US$125m

Sep 26 2020n/an/a

US$116m

Jun 27 2020n/an/a

US$110m

Mar 28 2020n/an/a

US$103m

Dec 28 2019US$2mUS$559k

US$101m

Sep 28 2019n/an/a

US$102m

Jun 29 2019n/an/a

US$109m

Mar 30 2019n/an/a

US$121m

Dec 29 2018US$2mUS$534k

US$126m

Sep 29 2018n/an/a

US$88m

Jun 30 2018n/an/a

US$81m

Mar 31 2018n/an/a

US$70m

Dec 30 2017US$1mUS$523k

US$63m

Compensation vs Market: Jim's total compensation ($USD1.79M) is below average for companies of similar size in the US market ($USD3.31M).

Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.


CEO

Jim Brown (54 yo)

7.3yrs

Tenure

US$1,793,140

Compensation

Mr. Jim Brown has been the President of USANA Health Sciences Inc. since November 2016 and served as its Chief Operating Officer since November 2013 until October 2019. He serves as Chief Executive Officer...


Leadership Team

NamePositionTenureCompensationOwnership
Kevin Guest
Executive Chairman6.8yrsUS$3.75m0.062%
$ 575.0k
Jim Brown
CEO & President7.3yrsUS$1.79mno data
G. Hekking
Chief Financial Officer6.8yrsUS$1.48m0.027%
$ 248.7k
Walter Noot
Chief Operating Officer4.4yrsUS$1.26mno data
David Mulham
Chief Field Development Officer7.1yrsUS$1.18m0.041%
$ 374.3k
Myron Wentz
Founder & Chairman Emeritus32.2yrsno data40.97%
$ 377.1m
John Cuomo
Executive Director of Product Development & Technology11.3yrsno datano data
Robert Sinnott
Chief Scientific Officer7.6yrsno datano data
Patrique Richards
Executive Director of Investor Relations & Business Developmentno datano datano data
P. Foukas
Chief Legal Officer5.7yrsno datano data
Daniel Macuga
Chief Communications & Marketing Officer12.3yrsUS$946.07k0.020%
$ 181.3k
Paul Jones
Chief People Officer3.1yrsUS$637.78k0.047%
$ 429.5k

7.1yrs

Average Tenure

57.5yo

Average Age

Experienced Management: USNA's management team is seasoned and experienced (7.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kevin Guest
Executive Chairman6.8yrsUS$3.75m0.062%
$ 575.0k
Myron Wentz
Founder & Chairman Emeritus3.8yrsno data40.97%
$ 377.1m
Gilbert Fuller
Lead Independent Director15.5yrsUS$250.54kno data
Peggie Pelosi
Independent Director5.3yrsUS$230.84k0.016%
$ 150.1k
Timothy Wood
Independent Director4.4yrsUS$218.64k0.025%
$ 227.8k
Christine Wood
Member of Scientific Advisory Councilno datano datano data
Monica Lewis
Member of Scientific Advisory Councilno datano datano data
Peter Rugg
Chairperson of Scientific Advisory Council20.2yrsno datano data
Bart Moore
Member of Scientific Advisory Councilno datano datano data
Heather Tick
Member of Scientific Advisory Councilno datano datano data
Frederic Winssinger
Independent Director7.8yrsUS$233.84k0.014%
$ 128.4k
J. Nixon
Independent Director1.7yrsUS$118.10k0.012%
$ 114.6k

6.0yrs

Average Tenure

67yo

Average Age

Experienced Board: USNA's board of directors are considered experienced (6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.